Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol

This report describes the occurrence of asymptomatic hyperkalemia induced by the sequential administration of metoprolol and carvedilol in an 81-year-old man with type II diabetes and stable stage III renal insufficiency. The potassium level rose to 5.6–5.7 mEq/L with metoprolol and normalized when...

Descripción completa

Detalles Bibliográficos
Autores principales: Barold, S. Serge, Upton, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205312/
https://www.ncbi.nlm.nih.gov/pubmed/30410801
http://dx.doi.org/10.1155/2018/7686373
_version_ 1783366171354988544
author Barold, S. Serge
Upton, Scott
author_facet Barold, S. Serge
Upton, Scott
author_sort Barold, S. Serge
collection PubMed
description This report describes the occurrence of asymptomatic hyperkalemia induced by the sequential administration of metoprolol and carvedilol in an 81-year-old man with type II diabetes and stable stage III renal insufficiency. The potassium level rose to 5.6–5.7 mEq/L with metoprolol and normalized when the agent was discontinued. However, the potassium level rose again to 5.6 mEq/L after the administration of carvedilol but the level normalized by halving the dose. The observations of hyperkalemia induced by two different β-blocker drugs in the same patient confirm that this side effect is common to all β-blocker drugs.
format Online
Article
Text
id pubmed-6205312
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-62053122018-11-08 Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol Barold, S. Serge Upton, Scott Case Rep Cardiol Case Report This report describes the occurrence of asymptomatic hyperkalemia induced by the sequential administration of metoprolol and carvedilol in an 81-year-old man with type II diabetes and stable stage III renal insufficiency. The potassium level rose to 5.6–5.7 mEq/L with metoprolol and normalized when the agent was discontinued. However, the potassium level rose again to 5.6 mEq/L after the administration of carvedilol but the level normalized by halving the dose. The observations of hyperkalemia induced by two different β-blocker drugs in the same patient confirm that this side effect is common to all β-blocker drugs. Hindawi 2018-10-15 /pmc/articles/PMC6205312/ /pubmed/30410801 http://dx.doi.org/10.1155/2018/7686373 Text en Copyright © 2018 S. Serge Barold and Scott Upton. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Barold, S. Serge
Upton, Scott
Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
title Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
title_full Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
title_fullStr Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
title_full_unstemmed Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
title_short Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
title_sort hyperkalemia induced by the sequential administration of metoprolol and carvedilol
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205312/
https://www.ncbi.nlm.nih.gov/pubmed/30410801
http://dx.doi.org/10.1155/2018/7686373
work_keys_str_mv AT baroldsserge hyperkalemiainducedbythesequentialadministrationofmetoprololandcarvedilol
AT uptonscott hyperkalemiainducedbythesequentialadministrationofmetoprololandcarvedilol

Ejemplares similares